Health in Morocco

1,025 indicators covering health for Morocco.

IndicatorLatest Year10-yr change Rank
Dengue fever deaths 0 2021 β€” 103rd
Death rate from cardiovascular disease age standardized ghe 379.21 2021 down 1.6% 25th
Deaths from cardiovascular disease type 544.93 2021 up 1.4% 40th
Death rate from rheumatic heart disease who ghe age standardized 1.65 2021 down 22.5% 79th
Death rate from hypertensive heart disease who ghe age standardized 39.45 2021 up 0.9% 32nd
Death rate from ischaemic heart disease who ghe age standardized 218.79 2021 down 0.1% 20th
Deaths from cardiovascular diseases by region 112,976 2021 up 41.0% 28th
Total disease burden who 11.55 million 2021 up 19.6% 50th
Burden of disease who 31,154 2021 up 6.1% 127th
Rate of disease burden from drug use disorders who 155.18 2021 down 7.5% 41st
Male female ratio suicides rates 1.43 2021 up 12.9% 191st
Number of people notified with new episode of TB in a given year 30,128 2021 up 1.2% 26th
Number of people diagnosed with new episode of pulmonary TB who are cl 1,108 2021 down 51.2% 61st
Number of people diagnosed with new episode of pulmonary TB who have e 13,809 2021 up 3.6% 12th
Antiretroviral therapy coverage for PMTCT 72.0% 2024 up 100.0% 49th
Share of women who are smoking 1.3 2022 down 27.8% 148th
Comparing the share of men and women who are smoking 24.7 2022 down 20.3% 102nd
Share of men who are smoking 24.7 2022 down 20.3% 102nd
Adults smoking 2007 2018 13 2022 down 20.7% 114th
Cases started on MDR-TB treatment 261 2024 up 112.2% 44th
Share healthy diet unaffordable 13.6 2024 up 3.0% 91st
Number of people diagnosed with new episode of pulmonary TB who are ba 14,410 2021 up 21.9% 29th
Raised fasting blood glucose (>=7.0 mmol/L) 13.7 2014 up 33.0% 26th
Mean fasting blood glucose (mmol/l) 5.48 2014 up 1.7% 78th
Raised fasting blood glucose (>= 7.0 mmol/L) 12.4 2014 up 49.4% 29th
Reported number of people requiring interventions against NTDs 81 2024 down 97.1% 134th
Child deaths from streptococcus by disease 28 2015 down 75.4% 64th
Percentage of total deaths due to NCDs overall and percentage of total 8.55 2019 down 47.2% 151st
Number of new leprosy cases 18 2024 down 28.0% 75th
Pharmacists 0.14 2024 down 94.6% 151st
Low birth weight prevalence 14.8% 2020 down 10.3% 32nd
Inactivated first-dose polio vaccine (IPV1) immunization coverage amon 95.0% 2025 up 187.9% 78th
Low birth weight number 97 2020 down 15.4% 26th
Number of new hivaids infections who 990 2024 down 17.5% 77th
Reported rabies deaths 17 2022 up 183.3% 18th
Number of current cigarette smokers, estimate 2.40 million 2030 down 13.7% 42nd
Incidence of malaria 0 per 1,000 population at risk 2024 β€” 79th
Reported number of children receiving antiretroviral therapy 825 2025 up 90.5% 47th
Concentrations of fine particulate matter 14.84 2023 up 11.8% 113th
Death rate road traffic injuries 17 2019 down 27.4% 77th
New or unknown treatment history cases: Pulmonary, bacteriologically c 14,746 2023 up 23.0% 30th
Cholera case fatality rate 0 1994 β€” 37th
Medical doctors not further defined 29,904 2023 up 74.7% 28th
Life satisfaction vs life expectancy 75.31 2023 up 4.4% 118th
Estimate of current cigarette smoking prevalence 8.2% 2030 down 22.6% 109th
Estimate of current cigarette smoking prevalence (%) 8.2% 2030 down 21.9% 109th
Tb patients tested positive for hiv 183 2021 up 346.3% 73rd
Number of children aged 6-59 months with anaemia 1,025 2019 up 0.9% 46th
Prevalence of anaemia in children aged 6-59 months 30.4% 2019 down 5.9% 87th
Number of deaths attributed to non-communicable diseases, by type of d 33,845 2019 up 46.9% 38th
Hepatitis B surface antigen (HBsAg) prevalence 0.0% 2024 β€” 132nd
Mean hemoglobin level of children aged 6-59 months 116 2019 up 0.9% 103rd
Estimated number of MDR/RR-TB incident cases 390 2024 down 13.3% 67th
Mortality caused by road traffic injury 17 per 100,000 population 2019 down 28.3% 77th
Mortality caused by road traffic injury, female 5.2 per 100,000 female population 2019 down 31.6% 113th
Mortality caused by road traffic injury, male 28.9 per 100,000 male population 2019 down 27.9% 73rd
Ipv vaccine coverage 95 2024 up 187.9% 82nd
Tb patients living with hiv receiving art 183 2021 up 553.6% 70th
HIV-positive TB patients on ART (antiretroviral therapy) 92.0% 2024 down 8.0% 90th
Hospital beds 7.3 2023 down 11.1% 137th